TransCode Therapeutics, Inc. (RNAZ) Stock Price History
Historical prices from 2021 to 2026
Loading 10-year price history...
RNAZ Historical Performance
Short-Term Returns
RNAZ Stock Price Trajectory (2021–2026)
As of May 8, 2026, TransCode Therapeutics, Inc. (RNAZ) trades at $8.00, representing a -19.6% return over the past year. The stock has delivered a -100.0% total return over five years (-90.4% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $999,999.00 on June 7, 2022. From this peak, RNAZ has corrected -100.0%, currently trading 19% below its 200-day moving average, suggesting potential weakness.
When compared to Healthcare sector peers ARWR (+496.9% 1Y), NTLA (+88.1% 1Y), and SRPT (-43.4% 1Y), RNAZ has underperformed the peer group average. Compare RNAZ vs ARWR →
RNAZ Historical Price Data (2025–2026)
Showing 30 of 1,214 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-07 | 7.50 | 8.25 | 7.48 | 8.00 | 11K | +6.38% |
| 2026-05-06 | 7.88 | 7.90 | 7.51 | 7.52 | 8K | -4.33% |
| 2026-05-05 | 8.01 | 8.08 | 7.86 | 7.86 | 5K | +1.55% |
| 2026-05-04 | 7.92 | 8.21 | 7.74 | 7.74 | 6K | -1.15% |
| 2026-05-01 | 7.99 | 8.40 | 7.83 | 7.83 | 5K | -2.25% |
| 2026-04-30 | 8.36 | 9.30 | 8.01 | 8.01 | 10K | -4.64% |
| 2026-04-29 | 8.54 | 8.54 | 8.16 | 8.40 | 10K | -0.59% |
| 2026-04-28 | 8.30 | 8.62 | 8.24 | 8.45 | 1K | +1.68% |
| 2026-04-27 | 8.70 | 8.79 | 8.30 | 8.31 | 2K | -2.46% |
| 2026-04-24 | 8.48 | 8.69 | 8.34 | 8.52 | 1K | -1.73% |
| 2026-04-23 | 9.10 | 9.10 | 8.55 | 8.67 | 5K | +0.85% |
| 2026-04-22 | 8.59 | 8.78 | 8.45 | 8.60 | 5K | -3.07% |
| 2026-04-21 | 8.65 | 8.87 | 8.65 | 8.87 | 1K | -0.17% |
| 2026-04-20 | 8.79 | 8.96 | 8.61 | 8.88 | 3K | +0.97% |
| 2026-04-17 | 9.00 | 9.00 | 8.61 | 8.80 | 4K | +1.15% |
| 2026-04-16 | 8.69 | 9.51 | 8.67 | 8.70 | 9K | -2.36% |
| 2026-04-15 | 8.90 | 9.15 | 8.55 | 8.91 | 6K | +0.11% |
| 2026-04-14 | 9.80 | 9.94 | 8.90 | 8.90 | 20K | +1.14% |
| 2026-04-13 | 7.92 | 8.80 | 7.88 | 8.80 | 6K | +7.19% |
| 2026-04-10 | 8.21 | 8.50 | 8.21 | 8.21 | 11K | -3.98% |
| 2026-04-09 | 8.43 | 8.57 | 8.22 | 8.55 | 3K | +2.27% |
| 2026-04-08 | 8.85 | 8.92 | 8.36 | 8.36 | 5K | -3.91% |
| 2026-04-07 | 8.62 | 9.07 | 8.62 | 8.70 | 6K | -2.90% |
| 2026-04-06 | 8.81 | 8.96 | 8.74 | 8.96 | 1K | -0.11% |
| 2026-04-02 | 8.82 | 8.98 | 8.56 | 8.97 | 1K | +3.22% |
| 2026-04-01 | 8.95 | 9.44 | 8.69 | 8.69 | 5K | +0.93% |
| 2026-03-31 | 8.56 | 8.80 | 8.46 | 8.61 | 12K | +0.35% |
| 2026-03-30 | 8.76 | 8.76 | 8.58 | 8.58 | 3K | -1.38% |
| 2026-03-27 | 8.87 | 9.32 | 8.52 | 8.70 | 7K | +1.87% |
| 2026-03-26 | 8.87 | 8.87 | 8.52 | 8.54 | 3K | 0.00% |
See RNAZ's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs RNAZ Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare RNAZ vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonRNAZ — Frequently Asked Questions
Quick answers to the most common questions about buying RNAZ stock.
How has RNAZ stock performed recently?
RNAZ declined -19.6% over the past year, below its 5-year annualized CAGR of -90.4%. The stock trades below its 200-day moving average, reflecting the downtrend.
What is RNAZ's all-time high price?
TransCode Therapeutics, Inc. reached $999999.00 on 2022-06-07. The 52-week high is $20.99. Current 1-year return of -19.6% places the stock further from historical peaks.
Where can I download RNAZ historical price data?
This page provides RNAZ daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2021-2026, downloadable in CSV format.